Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer
A phase 1/2 trial of Trifluridine/tipiracil, Bevacizumab in colorectal cancer, run by STCube, Inc., now recruiting.
Overview
Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer is a phase 1/2 interventional study registered as NCT06873763 by STCube, Inc., with 52 participants planned, started 2025-06-09 and due to reach its primary completion in 2025-12. Interventions recorded: Nelmastobart 800 mg+Trifluridine/Tipiracil+ Bevacizumab. Conditions listed: Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialSUNLIGHT
Shares Trifluridine/tipiracil, Bevacizumab, Colorectal cancer.
- TrialA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Shares Trifluridine/tipiracil, Colorectal cancer.
- TrialTATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Shares Trifluridine/tipiracil, Colorectal cancer.
- TrialA Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Shares Trifluridine/tipiracil, Colorectal cancer.
- TrialFOG-001 in Locally Advanced or Metastatic Solid Tumors
Shares Trifluridine/tipiracil, Bevacizumab, Colorectal cancer.
- TrialA Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Shares Trifluridine/tipiracil, Bevacizumab.
- TrialADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Shares Trifluridine/tipiracil, Bevacizumab.
- TrialStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
Shares Bevacizumab, Colorectal cancer.